ArticleFrontiers in cardiovascular medicine2025
Relationship between the stress-hyperglycemia ratio and atrial fibrillation recurrence risk after radiofrequency catheter ablation: a retrospective study.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between T cell exhaustion and the recurrence of atrial fibrillation after cryoballoon ablation.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The stress hyperglycemia ratio (SHR) is linked to cardiovascular outcomes. However, its role in predicting atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA) remains unclear. Therefore, this study investigated the SHR as a potential prognostic biomarker for post-RFCA AF recurrence. Methods: In this retrospective cohort study, 446 symptomatic non-valvular atrial fibrillation patients who underwent radiofrequency catheter ablation were followed for 12-26 months. The stress hyperglycemia ratio (SHR) was calculated as admission fasting blood glucose (mmol/L)/[1.59 × HbA1c (%)-2.59]. Patients were classified based on SHR levels. The primary endpoint was atrial fibrillation recurrence, and the secondary endpoints were cardiovascular events and a composite endpoint comprising relevant clinical outcomes. Results: AF recurrence occurred in 128 patients (28.7%). Patients in the recurrence group exhibited significantly higher SHR levels ( Conclusions: The increase in SHR is significantly correlated with atrial fibrillation recurrence and composite events after RFCA. These findings support its potential clinical application value in improving risk stratification and prognostic assessment of this patient population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.